7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancer stem cells (CSCs) represent a major source of treatment resistance and tumor progression. However, regulation of CSCs stemness is not entirely understood. Here, we report that TSPAN8 expression is upregulated in breast CSCs, promotes the expression of the stemness gene NANOG, OCT4, and ALDHA1, and correlates with therapeutic resistance. Mechanistically, TSPAN8 interacts with PTCH1 and inhibits the degradation of the SHH/PTCH1 complex through recruitment of deubiquitinating enzyme ATXN3. This results in the translocation of SMO to cilia, downstream gene expression, resistance of CSCs to chemotherapeutic agents, and enhances tumor formation in mice. Accordingly, expression levels of TSPAN8, PTCH1, SHH, and ATXN3 are positively correlated in human breast cancer specimens, and high TSPAN8 and ATXN3 expression levels correlate with poor prognosis. These findings reveal a molecular basis of TSPAN8-enhanced Sonic Hedgehog signaling and highlight a role for TSPAN8 in promoting cancer stemness.

          Abstract

          Tetraspanin 8 (TSPAN8) has been implicated in a number of different tumours, but the underlying mechanisms remain unclear. Here, in breast cancer the authors highlight a role for TSPAN8 in promoting tumorigenesis through the activation of Hedgehog signalling.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

          The dissemination of tumour cells is the prerequisite of metastases and is correlated with a loss of epithelial differentiation and the acquisition of a migratory phenotype, a hallmark of malignant tumour progression. A stepwise, irreversible accumulation of genetic alterations is considered to be the responsible driving force. But strikingly, metastases of most carcinomas recapitulate the organization of their primary tumours. Although current models explain distinct and important aspects of carcinogenesis, each alone can not explain the sum of the cellular changes apparent in human cancer progression. We suggest an extended, integrated model that is consistent with all aspects of human tumour progression - the 'migrating cancer stem (MCS)-cell' concept.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Hedgehog signalling in cancer formation and maintenance.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.

              The Hedgehog (Hh) signaling pathway functions as an organizer in embryonic development. Genetic analysis has demonstrated a critical role for the Hh pathway in mammary gland morphogenesis. Disruption of Patched1, a component of the Hh pathway, results in abnormal growth of mammary duct. Recent studies have shown constitutive activation of the Hh pathway in various types of malignancies. However, it remains unclear whether this pathway is activated in human breast cancer. Here, we determined the expression of the components, including Sonic Hh, Patched1, and Gli1, of the Hh pathway by immunohistochemical staining in a series of 52 human breast carcinomas. All of 52 tumors display staining of high intensity for Gli1 when compared with adjacent normal tissue. The nuclear staining ratio of Gli1 correlates with expression of estrogen receptor and histologic type. Exposure to cyclopamine, a steroidal alkaloid that blocks the Hh pathway, suppresses expression of Gli1 and the growth of the Hh pathway-activated breast carcinoma cells. These data indicate that the Hh pathway is a new candidate for therapeutic target of breast cancer.
                Bookmark

                Author and article information

                Contributors
                zhiminlu@zju.edu.cn
                whx365@126.com
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                28 June 2019
                28 June 2019
                2019
                : 10
                : 2863
                Affiliations
                [1 ]ISNI 0000 0004 0368 8293, GRID grid.16821.3c, Department of Oncology, Shanghai General Hospital, , Shanghai Jiao Tong University School of Medicine, ; Shanghai, 200080 China
                [2 ]ISNI 0000 0004 1936 973X, GRID grid.5252.0, Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, , Ludwig-Maximilians-University of Munich, ; Munich, Germany
                [3 ]Liyang People’s Hospital, Liyang, Jiangsu 213300 China
                [4 ]ISNI 0000 0004 0368 8293, GRID grid.16821.3c, Department of Breast-Thyroid-Vascular Surgery, Shanghai General Hospital, , Shanghai Jiao Tong University School of Medicine, ; Shanghai, 201620 China
                [5 ]ISNI 0000 0001 2323 5732, GRID grid.39436.3b, Shanghai Key Laboratory of Molecular Imaging, , Shanghai University of Medicine and Health Sciences, ; Shanghai, 201318 China
                [6 ]ISNI 0000 0000 9247 7930, GRID grid.30055.33, School of Pharmaceutical Science and Technology, , Dalian University of Technology, ; Dalian, 116024 China
                [7 ]ISNI 0000000119573309, GRID grid.9227.e, Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, , Chinese Academy of Sciences, ; Shanghai, 201203 China
                [8 ]ISNI 0000 0004 1759 700X, GRID grid.13402.34, Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, and Institute of Translational Medicine, , Zhejiang University School of Medicine, ; Hangzhou, 310029 China
                Article
                10739
                10.1038/s41467-019-10739-3
                6599078
                31253779
                71105fc2-e34c-43e3-b772-d04f0307d493
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 12 July 2018
                : 21 May 2019
                Funding
                Funded by: FundRef https://doi.org/10.13039/100012543, Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund);
                Award ID: 17JC1404400
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                breast cancer,cancer stem cells
                Uncategorized
                breast cancer, cancer stem cells

                Comments

                Comment on this article